March 16, 2024
Discussing medicine
Nephrologist Dr Carlos Ramirez Sandoval (centre) discusses developments in the fight against kidney disease with Dennis Grant, chief executive officer of Cari-Med Group Limited, and Alton Ellington (right), senior agency manager of the Cari-Med Pharmaceutical Division. Dr Sandoval was the guest presenter at a function hosted by Bayer on February 29 at the Jamaica Pegasus to launch Finerenone, a drug which has been shown to delay the progression of kidney damage in patients with type 2 diabetes. Chronic kidney disease is one of the leading causes of morbidity and mortality in Jamaica.